🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Primary Hypercholesterolemia

A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284 NCT06884098Phase 11 site📍 Seoul Addpharma Inc. · Tests: AD-228B, AD-2284 A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia NCT07206472n/a38 sites📍 Belo Horizonte📍 Belo Horizonte📍 Belo Horizonte Daiichi Sankyo · Tests: Combination of bempedoic acid and ezetimibe A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia NCT06568471Phase 318 sites📍 Beijing📍 Beijing📍 Beijing Hasten Biopharmaceutical Co., Ltd. · Tests: Lerodalcibep, matching placebo Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea) NCT06770543n/a4 sites📍 Yangsan📍 Busan📍 Seoul Novartis Pharmaceuticals · Tests: Inclisiran A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia NCT07421297Phase 32 sites📍 Beijing📍 Beijing CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Tests: SYH2053 injection, SYH2053 injection placebo Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days NCT07614958Phase 31 site📍 Stockton-on-Tees A. Menarini International Licensing S.A. · Tests: Obicetrapib 10 mg/Bempedoic Acid Placebo, Bempedoic Acid 180mg/Placebo Obicetrapib A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib NCT06314919n/a1 site📍 Seoul Boryung Pharmaceutical Co., Ltd EAS Familial Hypercholesterolaemia Studies Collaboration NCT04272697n/a1 site📍 London Imperial College London
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy